BR Shetty: $15 Billion Suit Against Bank of Baroda Filed in Bombay High Court

• Dr. BR Shetty has filed a commercial suit in the Bombay High Court against Bank of Baroda and others.
• The lawsuit seeks over $15 billion in damages, alleging the bank's complicity in a major fraud.
• Shetty claims former executives Prasanth and Promoth Manghat siphoned funds and forged his signature.
• The suit alleges Bank of Baroda officials executed "round-tripping" transactions and ignored over 100 AML alerts.
• Bank employees are accused of accepting illegal gratification to hide borrowings from auditors.

Crucially, the BR Shetty $15 billion suit against Bank of Baroda posits that the financial institution was not merely an unwitting observer to the alleged fraud but was, in fact, an active participant and a key instrument through which the misconduct was executed.

Dr. Bavaguthu Raghuram (BR) Shetty, the founder of prominent UAE-based entities NMC Healthcare and UAE Exchange, has initiated a significant commercial suit in the Bombay High Court. This legal action targets Bank of Baroda (BoB) and other parties, seeking damages that exceed an astounding $15 billion, which translates to approximately ₹1.43 lakh crore. The lawsuit, formally titled "Dr BR Shetty v. Bank of Baroda & Ors.", was lodged by Dr. Shishir Shetty, acting as Dr. Shetty's power of attorney holder.

The defendants named in this extensive litigation include Bank of Baroda, several of its officers, and former NMC executives Prasanth and Promoth Manghat. The core of the complaint stems from a period between 2012 and 2017, during which Dr. Shetty asserts he had stepped back from the day-to-day management of his businesses to focus on philanthropic endeavors. It was during this interval that the Manghat brothers allegedly assumed complete control over the companies' financial operations.

According to the suit, the Manghat brothers are accused of systematically siphoning funds from the companies. This alleged scheme involved the creation and utilization of sham supplier entities. Furthermore, Dr. Shetty claims that his signature was illicitly copied from an electronic template and subsequently affixed to loan guarantees without his knowledge or consent, implicating him in financial obligations he did not authorize.

Crucially, the BR Shetty $15 billion suit against Bank of Baroda posits that the financial institution was not merely an unwitting observer to the alleged fraud but was, in fact, an active participant and a key instrument through which the misconduct was executed. Dr. Shetty's legal filing specifically alleges that Bank of Baroda officials engaged in "round-tripping" transactions. This sophisticated financial maneuver involved establishing accounts for fictitious shell suppliers and then circulating money through these accounts in a circular fashion, primarily to artificially inflate the perceived profitability of NMC Healthcare and related entities.

The allegations against Bank of Baroda extend to serious lapses in its anti-money laundering (AML) protocols. The lawsuit claims that the bank deliberately disregarded more than 100 internal AML alerts that should have flagged suspicious activities. Compounding these alleged failures, the suit further asserts that bank personnel accepted various forms of illegal gratification, including luxury electronic goods and a high-value Rolex watch. These alleged bribes were purportedly given to conceal substantial group borrowings from statutory auditors, thereby undermining financial transparency and regulatory oversight.

This Bombay High Court commercial suit highlights significant compliance and litigation risks for financial institutions. The accusations of ignored AML warnings and alleged complicity in large-scale financial misconduct, as detailed in the Prasanth Promoth Manghat lawsuit context, underscore the critical importance of robust internal controls and stringent anti-money laundering frameworks. The outcome of this case could set important precedents regarding the accountability of banks in detecting and preventing sophisticated financial fraud, particularly when their own employees are implicated in facilitating such schemes. The Bank of Baroda AML failures, if proven, would represent a profound breach of trust and regulatory obligations.

This case highlights significant compliance and litigation risks for financial institutions regarding internal fraud detection, anti-money laundering protocols, and potential complicity in large-scale financial misconduct. Lawyers should advise banking and corporate clients on strengthening internal controls and AML frameworks to prevent similar exposures and potential liabilities.

Source: Original reporting via legal news source